No black box warning on record for Contrave Extended-Release
As of the latest FDA labeling reviewed, Contrave Extended-Release (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Contrave Extended-Release medicine page for the complete safety profile.